- Home
- BBAR vs APLS Comparison
BBAR vs APLS Comparison
Compare BBAR & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BBAR | APLS |
|---|---|---|
| Founded | 1886 | 2009 |
| Country | Argentina | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.7B |
| IPO Year | 1997 | 2015 |
Fundamental Metrics
Financial Performance| Metric | BBAR | APLS |
|---|---|---|
| Price | $13.73 | $17.93 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 21 |
| Target Price | $17.00 | ★ $31.65 |
| AVG Volume (30 Days) | 672.3K | ★ 1.9M |
| Earning Date | 03-04-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.82% | N/A |
| EPS Growth | N/A | ★ 112.50 |
| EPS | N/A | ★ 0.20 |
| Revenue | N/A | ★ $1,003,782,000.00 |
| Revenue This Year | $12.21 | N/A |
| Revenue Next Year | $13.00 | $18.21 |
| P/E Ratio | ★ $26.78 | $89.73 |
| Revenue Growth | N/A | ★ 28.46 |
| 52 Week Low | $7.76 | $16.10 |
| 52 Week High | $23.10 | $30.48 |
Technical Indicators
Market Signals| Indicator | BBAR | APLS |
|---|---|---|
| Relative Strength Index (RSI) | 40.88 | 29.14 |
| Support Level | $13.63 | $17.16 |
| Resistance Level | $17.36 | $20.42 |
| Average True Range (ATR) | 0.84 | 0.69 |
| MACD | 0.05 | -0.14 |
| Stochastic Oscillator | 41.31 | 17.53 |
Price Performance
Historical ComparisonAbout BBAR Banco BBVA Argentina S.A. ADS
Banco BBVA Argentina SA is a banking services provider in Argentina. It provides financial assistance to large corporations, small and medium-sized companies, as well as individuals. It bank provides services through retail, corporate, investment banking, and Small and medium-sized companies divisions. Through the retail banking segment, it provides banking products and services to individuals, corporate banking deals with services to corporates, and the small and medium-sized companies segment focuses on foreign trade, agricultural business, and digital products.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.